Related Experiment Video
Updated: Mar 5, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Immediate access to antiretroviral therapy is important in children living with HIV
Sangeeta Das Bhattacharya1, Bikas K Arya1
1School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal, India.
Insights
Delayed antiretroviral therapy (ART) in children with perinatal HIV significantly hinders immunization response and growth. Early ART access is crucial for HIV-infected Indian children, irrespective of CD4 count, aligning with global treatment guidelines.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Pneumonia prevention in HIV-infected children is a critical public health concern.
- Antiretroviral therapy (ART) is central to managing pediatric Human Immunodeficiency Virus (HIV).
- Global guidelines for initiating ART in children are evolving, necessitating timely updates.
Observation:
- A case report details a child with perinatal HIV followed for 30 months.
- The study focused on a prospective cohort investigating pneumonia prevention strategies.
- This case highlights the impact of delayed ART initiation on child health outcomes.
Findings:
- Delayed access to antiretroviral therapy (ART) negatively affects immunization response in HIV-infected children.
- Impaired growth was observed in children with delayed ART initiation.
- The findings underscore the importance of timely ART for pediatric HIV management.
Implications:
- This case emphasizes the urgent need for accessible ART for all HIV-infected Indian children, regardless of CD4 T-cell count.
- The findings support the World Health Organization's (WHO) revised guidelines on early ART initiation.
- Timely ART access is essential for improving long-term health, growth, and immune reconstitution in vertically HIV-infected children.
Abstract:
This article reviews a case of a child with perinatal HIV followed for 30 months during a prospective cohort study on pneumonia prevention in HIV-infected children. The point of this case report is to illustrate how delayed access to antiretroviral therapy (ART) in HIV-infected children impacts immunization response and growth. Given the WHO's early release guideline changes on ART recommendations and the expected full revised guidelines coming out this year, this article is a timely discussion on the need for access to ART for HIV infected Indian children regardless of CD4 count.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Excretion
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections
Retroviruses
Pharmacokinetics in Pediatric Patients: Drug Metabolism

